Stoke Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States201-500 Employees
Stoke Therapeutics is a mid-sized biotechnology company focused on restoring protein expression through RNA-based medicines. Its approach leverages antisense oligonucleotides to selectively augment the levels of naturally occurring proteins. The initial program targets central nervous system and ocular diseases caused by haploinsufficiency, where about half of normal protein is lacking, with proof of concept demonstrated in other tissues. The company is headquartered in Bedford, Massachusetts. Its lead candidate, zorevunersen, is in a Phase 3 trial for Dravet syndrome, and recent reports indicate a Phase III launch in collaboration with Biogen.